Join

Compare · EMBC vs WST

EMBC vs WST

Side-by-side comparison of Embecta Corp. (EMBC) and West Pharmaceutical Services Inc. (WST): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both EMBC and WST operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • WST is the larger of the two at $22.22B, about 110.8x EMBC ($200.5M).
  • Over the past year, EMBC is down 66.1% and WST is up 42.4% - WST leads by 108.5 points.
  • EMBC has been more active in the news (5 items in the past 4 weeks vs 4 for WST).
  • WST has more recent analyst coverage (16 ratings vs 9 for EMBC).
PerformanceEMBC-66.15%WST+42.38%
2025-06-09+0.00%2026-06-08
MetricEMBCWST
Company
Embecta Corp.
West Pharmaceutical Services Inc.
Price
$3.35-0.89%
$318.69+1.36%
Market cap
$200.5M
$22.22B
1M return
-7.06%
-1.02%
1Y return
-66.15%
+42.38%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NYSE
IPO
News (4w)
5
4
Recent ratings
9
16
EMBC

Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

WST

West Pharmaceutical Services Inc.

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Latest EMBC

Latest WST